Over the last week, shares of Moderna Inc.(MRNA) jumped from a low of $46.13 to $64.34, and could accelerate higher. All after MRNA has advanced late-stage development of its coronavirus vaccine. Better, it just finalized the Phase 3 study protocol based on feedback from U.S. FDA. The randomized, 1:1 placebo-controlled trial is expected to include […]

Zynga Inc. (ZNGA) is still one of the most explosive gaming stocks on the market. Since bottoming out in March 2020 at $5.65, the ZNGA stock price is now up to $9.10 – and accelerating higher. Not only did ZNGA just buy Peak for $1.8 billion, giving it access to a popular lineup of puzzle […]

Since bottoming out at $89 in March 2020, shares of Boeing (BA) exploded to $204. Analysts appear just as bullish on BA, with Seaport Global initiating coverage of the stock with a buy rating, and a target price of $277. Goldman Sachs also raised its price target on Boeing from $209 to $238 with a […]

Shares of electric vehicle maker, Nio (NIO) have faced plenty of pressure this year. However, it appears the EV stock has turned a corner after reporting another month of record deliveries. For May 2020, the company delivered 3,436 vehicles.  That included the delivery of 2,685 ES6s and 751 ES8s.  “In May, we achieved record-high monthly […]

Since mid-March 2020, DIS stock soared from a low of $79.07 to $119. However, the recovery may have only just begun for DIS, especially with a good deal of fear priced into the stock. Not only will the company just reopen Shanghai Disneyland, it set a July 11 date to start reopening Disney World, as […]

Enphase Energy (ENPH) has been incredibly explosive. Since hitting a low of $21.49 in March 2020, ENPH has rallied to $58.44. Not only did it report impressive earnings, but it also just announced a collaboration with the University of Washington for a 100% renewables grid. According to ENPH’s latest press release, “Under the heading, A Scalable […]

Since April 2020, FATE stock rocketed from a low of $19.92 to $35.23, as it moves progresses with cellular immunotherapies for cancer and immune disorders. Just days ago, FATE announced the U.S. FDA cleared its investigational new drug (IND) application for FT538, the first CRISPR-edited iPSC-derived cell therapy. FT538 is an off the shelf natural […]

Shares of electric vehicle maker, Nio (NIO) have faced plenty of pressure this year. Most recently, on news China will cut subsidies on new energy vehicles, such as electric cars by 10% this year. Under China’s new plan, it will also extend subsidies for buying NEVs to 2022, and tax exemptions on purchases for two […]

Fate Therapeutics (FATE) just posted first quarter 2020 highlights, including: “We are encouraged by the resilience of our employees, our clinical trial investigators and participating patients, and our collaboration partners in the face of the challenge posed by the global pandemic. Like others, we have been affected by COVID-19, which has impacted clinical site initiation, […]

ZNGA posted a first quarter loss of $103.9 million, or 11 cents a share, as compared with a year-earlier loss of $128.8 million, or 14 cents. Revenue rocketed 52% higher to $403.8 million from $265.4 million year over year. Analysts were only looking for a loss of a penny a share on sales of $389 […]